Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment for Bladder Cancer

NCT01955408 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.

NCT NCT01955408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01955408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment for Bladder Cancer
Lead sponsor
Meir Medical Center
Phase
Observational
Overall status
Completed
Start date
September 30, 2013
Completion date
December 31, 2016
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, overactive bladder, synergo